Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32) - Wikidata - wikimedia - TriplyDB

Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)

Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)

http://www.wikidata.org/entity/Q28143651

about

BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B Interchangeable binding of Bcl10 to TRAF2 and cIAPs regulates apoptosis signaling Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas Bcl10 can promote survival of antigen-stimulated B lymphocytes Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity Accumulation of BCL10 at the perinuclear region is required for the BCL10-mediated nuclear factor-kappa B activation Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex.CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1 Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphoma Equine herpesvirus protein E10 induces membrane recruitment and phosphorylation of its cellular homologue, bcl-10 Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway Functional characterization of zebrafish (Danio rerio) Bcl10 Physical and functional interaction of CARMA1 and CARMA3 with Ikappa kinase gamma-NFkappaB essential modulator A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma Caspase recruitment domain (CARD)-dependent cytoplasmic filaments mediate bcl10-induced NF-kappaB activation BCL10 mediates lipopolysaccharide/toll-like receptor-4 signaling through interaction with Pellino2 The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.Lack of BCL10 mutations in Hodgkin's disease-derived cell lines.A loss-of-function RNA interference screen for molecular targets in cancer.Establishment of a pipeline to analyse non-synonymous SNPs in Bos taurus Auto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation.Diffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis Oncogenic activation of NF-kappaB.CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.BCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle-cell lymphoma, has an independently expressed homolog on 1p22-p31, BCMSUN-like.Molecular diagnostic approach to non-Hodgkin's lymphoma.Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.Molecular basis of lysophosphatidic acid-induced NF-κB activation Lymphoid malignancies: the dark side of B-cell differentiation.Caspases: conductors of the cell death machinery in lymphoma cells.

P2860

Q24290366-B691986F-B4F1-4C13-A731-5D1A9F1D08E9 Q24290440-8B1DD5D6-7765-44C9-B43C-CC2534ED9678 Q24291474-343D9857-E631-4A3B-A34F-588C7C8D3248 Q24298225-299B6BE4-8026-4371-90A5-5B3966019598 Q24300394-C2AD03F4-C15A-4DB8-BBA0-8EF50A3ACC53 Q24301605-A5FC7C90-8763-4282-929D-A295D6D99B81 Q24306407-9288092E-327A-4042-A726-546A3215644A Q24318385-2582EDDB-368C-4219-AB06-D2402B82B17A Q24336767-C8744D6D-3146-4D94-BA8F-06222541D304 Q24534877-B9DC6B77-9514-425E-A72F-383D78A89B7A Q24630605-F9C5A0F2-6489-4CE5-BDCB-F5EF32A39F00 Q26851166-C914C190-57D3-48F8-8B40-6924AEB77D83 Q28118973-C0B6E7E2-E1DE-4FB5-8BE5-F0B87CACAA0D Q28141188-37FFBDF7-2615-4E9D-9AA5-02261A975FF1 Q28198772-95FC4048-32EE-43B9-B5C7-F08D187598F1 Q28206030-FB1FDA3C-0C6F-47A2-9328-8088669ACBD6 Q28260096-0A61883F-26E1-462D-B2EE-F38C79D9C39C Q28265675-716DD1CB-70B4-493F-AD9B-1856638D0DBE Q28287278-B13AD6F7-1181-4F70-810D-297363F503CD Q28295777-6D260F30-5174-4BF1-ABDA-2724B74BA3BB Q28306819-477A65D5-1974-48DB-AFC8-E6644C6B1820 Q28573777-54581F04-2B30-497A-9175-446D0C786AEA Q28589369-BB649523-C22E-4A47-B9DA-90D00DA4D149 Q30157639-66AB74E1-0BC2-4543-88C4-848C2C592A96 Q33180518-08BC0DD2-61A1-4C70-95AE-AED59F4423A4 Q33237976-073BB046-6CDF-4AF1-AAA7-4614D7200340 Q33264594-EE5304D9-3564-4746-8867-B1C212957721 Q33417259-F090EEA3-61AE-4648-8035-CE3A31C0BABF Q33581388-B59DABF9-7FC7-4486-9D34-87E10A1ACF9D Q33622342-BC3BE8CF-0E5B-4C61-B5CC-18E5F6BA58BC Q33781603-EEBFFFBF-35E9-4A02-9BAB-27B7C9F32F6F Q33849388-41CB1BE3-E27F-421E-9233-785AB3087199 Q33885629-C16767D0-92AA-40E0-BFD1-C19DD71AD11D Q33889168-3A5A4CB2-F224-4B23-8B08-BA287EA440D8 Q33924832-6EA78175-B8BF-443B-BE4A-28BA63C76555 Q33936373-52D41B37-2DBE-4F59-9331-202AD8A3FB8E Q34080225-C95AE533-AF50-4498-933B-14F5A14EDDCC Q34126537-D97275EE-6FAF-49CB-9598-6FD59AA240F3 Q34162187-8F1FFFBA-C6F9-46DD-BD8F-B405E726DED1 Q34265185-17349F13-F625-49E1-8E50-45861C78F85A

P2860

Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)

http://www.wikidata.org/entity/Q28143651

description

1999 nî lūn-bûn

@nan

1999 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)

@ast

Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)

@en

Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)

@nl

type

label

Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)

@ast

Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)

@en

Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)

@nl

prefLabel

Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)

@ast

Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)

@en

Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)

@nl

P1433

Q28143651-500DF648-2D81-4462-A4E3-162361268477

P1476

Q28143651-08172912-243D-4766-93F9-82A3597D8EEB

P2093

Q28143651-06A0642E-9905-422A-B136-F2C0973B29E6

Q28143651-17F8CF73-45E5-4169-B205-C7AFED278B5E

Q28143651-2A0098C5-1FEE-46DB-96C8-FD44FDEA34D6

Q28143651-2E68A2F9-2F54-4D82-94F6-04EA4AD09497

Q28143651-5442D528-4DF7-4D93-86C5-0D00B6F7BA76

Q28143651-55772A12-7941-43A1-9CB6-EF352580B849

Q28143651-6EE61C66-BF11-40A2-8868-AD7E678530EA

Q28143651-85C790D2-9B7B-4F95-AA49-AEC0D272B49F

Q28143651-8D549E1E-2DBC-474E-B0AD-7A72E0000EA2

Q28143651-988BF33F-5E76-4A53-9F66-A2BEDB3CF093

P2888

Q28143651-6CDE7C47-C07A-45C9-A501-2487339607AB

P304

Q28143651-BB0BD2F2-74AC-4413-9492-1DEB7B928F4E

P31

Q28143651-599E9440-BDEB-4951-A6E2-08DD180DC964

P3181

Q28143651-0746AFA7-A2AB-46CA-9918-1118CF39FE06

P356

Q28143651-AC52A6BC-3406-4AE4-94EC-72730A8AEFCA

P407

Q28143651-28A4E8B0-3F46-42BF-8EC8-5EFCA4494763

P433

Q28143651-5BEB15E2-3EDE-49D7-B5DD-BEAA31ACD621

P478

Q28143651-09FA9C0B-8768-45FF-B2D8-7A90CFD68CDE

P577

Q28143651-B4FFBA76-6CB6-4BF5-91C1-814522A90361

P5875

Q28143651-9BE3149C-1227-4377-8E31-741721A3D19D

P698

Q28143651-8BAB8E13-9ED6-4DC1-83C9-7BC118C24B32

P921

Q28143651-BCC3801A-04C0-4D00-8860-B9BB0C82EB2C

P3181

P356

P1433

Nature Genetics

P1476

Inactivating mutations and ove ...... lymphoma with t(1;14)(p22;q32)

@en

P2093

A Rosenthal

http://www.w3.org/2001/XMLSchema#string

B Hinzmann

http://www.w3.org/2001/XMLSchema#string

B Schlegelberger

http://www.w3.org/2001/XMLSchema#string

C W Naeve

http://www.w3.org/2001/XMLSchema#string

D D Weisenburger

http://www.w3.org/2001/XMLSchema#string

E Callet-Bauchu

http://www.w3.org/2001/XMLSchema#string

G Beckmann

http://www.w3.org/2001/XMLSchema#string

G Salles

http://www.w3.org/2001/XMLSchema#string

H Nowotny

http://www.w3.org/2001/XMLSchema#string

K M Rakestraw

http://www.w3.org/2001/XMLSchema#string

P2888

P304

63-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1186120

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/8767

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

1999-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12978523

http://www.w3.org/2001/XMLSchema#string

P698

10319863

http://www.w3.org/2001/XMLSchema#string

P921